What do the patients expect from us? An anthropological perspective

ESGO eAcademy, Luis Chiva, 332135

HIPEC and the biologic rationale

ESGO eAcademy, O. Zivanovic, 330601

Image-guided surgery

ESGO eAcademy, Alexander L. Vahrmeijer, 330600

HRD testing in ovarian cancer

ESGO eAcademy, Anniina Färkkilä, 330599

Role of maintenance therapy

ESGO eAcademy, Christian Marth, 330598

Genetic profiling for the management of ovarian cancer

ESGO eAcademy, Sandro Pignata, 330597

Cervical cancer in pregnancy

ESGO eAcademy, Frederic Amant, 330595

New classification approaches for cervical carcinoma

ESGO eAcademy, Ben Davidson, 330594

Targeted therapies in endometrial carcinoma: Where we are?

ESGO eAcademy, Isabelle Ray-Coquard, 330593

Implementing molecular endometrial cancer classification in clinic

ESGO eAcademy, Tjalling Bosse, 330592

Thoracic anatomical landmarks and VATS cardiophrenic lypmh node resection in advanced ovarian cancer

ESGO eAcademy, Faculty / Presenters, 330161

Tumour Board 7: Management of Cervical Cancer Patients

ESGO eAcademy, Faculty / Presenters, 330160

Role of PARP inhibitors in Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 330132

Step 1: Registration form

ESGO eAcademy, Faculty / Presenters, 325813

Right upper abdomen debulking in ovarian cancer

ESGO eAcademy, Faculty / Presenters, 325811

Role of radical hysterectomy in patients with early-stage high-grade neuroendocrine cervical carcinoma: a NeCTuR study

ESGO eAcademy, Gloria Salvo, 324034

Uterine manipulator in endometrial cancer: a video is worth a thousand words

ESGO eAcademy, Faculty / Presenters, 322741

Introduction to Robotics: overview the benefits of robotics in GO

ESGO eAcademy, Faculty / Presenters, 318220

Tumour Board 6: Management of Ovarian Cancer Patients

ESGO eAcademy, Faculty / Presenters, 322683

Modern surgical staging for endometrial cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 322378

ENYGO LiFE Report - 12th edition

ESGO eAcademy, Faculty / Presenters, 322377

Modern surgical staging for endometrial cancer

ESGO eAcademy, Nadeem R. Abu-Rustum, 321298

Extraperitoneal paraaortic lymphadenectomies

ESGO eAcademy, Faculty / Presenters, 315511

COVID-19 Vaccination for patients under the cancer therapy

ESGO eAcademy, Faculty / Presenters, 318267

On-Demand - Introduction to Robotics: overview the benefits of robotics in GO

ESGO eAcademy, Faculty / Presenters, 318219

Right upper quadrant peritonectomy - FAQ

ESGO eAcademy, Artem Stepanyan, 315632

Right upper quadrant peritonectomy - Transperitoneal Approach

ESGO eAcademy, Artem Stepanyan, 315631

Right upper quadrant peritonectomy - Retroperitoneal Approach

ESGO eAcademy, Artem Stepanyan, 315630

Complete tumor resection from porta hepatis in a patient with recurrent epithelial ovarian cancer

ESGO eAcademy, Faculty / Presenters, 315629

The new ESGO-ISUOG-ESGE-IOTA consensus on the pre-operative assessment of ovarian and tubal pathology

ESGO eAcademy, Christina Fotopoulou, 315526

Step 1: Registration

ESGO eAcademy, Faculty / Presenters, 315512

Uterine transposition for uterine preservation

ESGO eAcademy, Faculty / Presenters, 314426

Tumour Board 5: Cancer in Pregnancy

ESGO eAcademy, Faculty / Presenters, 315062

Gynaecological Cancer during pregnancy, with an emphasis on chemotherapy

ESGO eAcademy, Frederic Amant, 314824

Uterine Transposition: Robotic uterine transposition for a cervical cancer patient with pelvic micrometastases after conization and pelvic lymphadenectomy

ESGO eAcademy, Faculty / Presenters, 314787

Inspiring leaders interview with prof. Ignace Vergote

ESGO eAcademy, Agnieszka Rychlik, 314762

Radical hysterectomy step by step

ESGO eAcademy, Faculty / Presenters, 314118

Step 1 - Registration for Uterine transposition for uterine preservation

ESGO eAcademy, Faculty / Presenters, 314427

Open Surgery is the NEW Standard of Care: PRO

ESGO eAcademy, Pedro Ramirez, 314408

Open Surgery is the NEW Standard of Care: CON

ESGO eAcademy, Mario Leitao Jr., 314407

Surgery in recurrent ovarian cancer? CON

ESGO eAcademy, Robert L Coleman, 314406

Surgery in recurrent ovarian cancer? PRO

ESGO eAcademy, Andreas du Bois, 314405

Systemic therapy in cervical cancer: from antiangiogenic to immunotherapy

ESGO eAcademy, Domenica Lorusso, 314404

FIGO classification and its impact on management

ESGO eAcademy, René Pareja, 314403

Radiotherapy options in advanced cervical cancer. Is there role of neoadjuvant chemotherapy?

ESGO eAcademy, Alejandra Martinez, 314402

Risk groups or molecular profile: what should we do from now on?

ESGO eAcademy, Xavier Matias-Guiu, 314401

Adjuvant radiotherapy in endometrial cancer

ESGO eAcademy, Anuja Jhingran, 314400

PARPi in front line: current challenges and future directions

ESGO eAcademy, AINHOA MADARIAGA, 314399

Step 1 - Registration

ESGO eAcademy, Faculty / Presenters, 314119

State of the Art ESGO Conference Closing Remarks

ESGO eAcademy, Faculty / Presenters, 313678

Open vs MIS approach for radical hysterectomy and radical hysterectomy: limits and challenges

ESGO eAcademy, Pedro Ramirez, 312881

Decision making processes, patients selection and allocation of healthcare resources in times of crisis

ESGO eAcademy, Nadeem R. Abu-Rustum, 312527

Establishing SLN as standard of care in endometrial and cervical cancer?

ESGO eAcademy, Denis Querleu, 312526

FIGO stage IV and metastatic endometrial cancer

ESGO eAcademy, Christian Marth, 312525

Endometrial cancer , stage IV and metastatic. Set up the case

ESGO eAcademy, Mansoor Raza Mirza, 312524

Endometrial cancer adjuvant therapy. State of the art lecture

ESGO eAcademy, Domenica Lorusso, 312523

Endometrial cancer adjuvant therapy - Set up the case

ESGO eAcademy, Remi Nout, 312522

Endometrial cancer surgery - State of the art lecture

ESGO eAcademy, Philippe Morice, 312521

Endometrial cancer - Set up the case

ESGO eAcademy, Jalid Sehouli, 312520

ESGO-ESTRO-ESP endometrial cancer guidelines

ESGO eAcademy, Nicole Concin, 312519

Major advances in gynaecological cancers 2020 - Discussion

ESGO eAcademy, Faculty / Presenters, 313668

Advances in targeted therapy in gynaecological cancers

ESGO eAcademy, Jonathan Ledermann, 312518

Relapse surgery in ovarian cancer - Improving outcome of our patients

ESGO eAcademy, Andreas du Bois, 312517

Major advances in gynaecological cancers 2020 - Part II - Discussion

ESGO eAcademy, Faculty / Presenters, 313667

Three-minute thesis

ESGO eAcademy, Faculty / Presenters, 313681

Role of immunotherapy in gynaecological malignancies

ESGO eAcademy, Antonio Gonzalez Martin, 312516

The ABRAX trial and what next?

ESGO eAcademy, David Cibula, 312515

Industry symposium: Current State of the Art in the Management of Endometrial Cancer

ESGO eAcademy, Faculty / Presenters, 313084

Industry symposium - sponsored by Intuitive Surgical: Honoring the past 10 years of robotic-assisted surgery and paving the way for the next decade

ESGO eAcademy, Faculty / Presenters, 313583

10:20- 11:45 CET - NEW Endometrial cancer guidelines & Endometrial cancer surgery

ESGO eAcademy, Faculty / Presenters, 313072

8:00 - 10:00 CET - Major advances in gynaecological cancers 2020 - Part II

ESGO eAcademy, Faculty / Presenters, 313071

Endometrial cancer adjuvant therapy

ESGO eAcademy, Faculty / Presenters, 313073

Endometrial cancer (stage 4 & metastatic), Controversies & Closing remarks

ESGO eAcademy, Faculty / Presenters, 313074

Industry symposium: Honoring the past 10 years of robotic-assisted surgery and paving the way for the next decade

ESGO eAcademy, Faculty / Presenters, 313083

NIRAPARIB in patients with newly diagnosed advanced ovarian BRCAM cancer: A post hoc analysis of the PRIMA/ENGOT-OV26/GOG-3012 trial

ESGO eAcademy, Jacob Korach, 312514

Significant variation in treatment and survival outcomes in stage 2-4 ovarian cancer in England: results from the national ovarian cancer feasibility audit pilot

ESGO eAcademy, Sudha Sundar, 312513

Increased institutional surgical experience in robot-assisted radical hysterectomy for early stage cervical cancer reduces recurrence rate. Results from a nationwide study.

ESGO eAcademy, Linnea Ekdahl, 313494

A randomised phase II study of NINTEDANIB (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36)

ESGO eAcademy, Ros Glasspool, 312512

Attitudes towards risk reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: A COHORT study

ESGO eAcademy, Faiza Gaba, 312813

Early salpingectomy (tubectomy) with delayed oophorectomy as an alternative for risk-reducing salpingo-oophorectomy to improve quality of life in women with a BRCA1/2 pathogenic variant (TUBA study): A prospective multicenter preference trial

ESGO eAcademy, Miranda P. Steenbeek, 312812

Impact of the covid pandemic on gynaecological cancer surgery – results from the covidsurg gynaecological cancer international study

ESGO eAcademy, Sudha Sundar, 312511

Efficacy of niraparib therapy in patients with newly diagnosed advanced ovarian cancer by brcawt status: prima/engot-ov26/gog-3012 study

ESGO eAcademy, Elena Ioanna Braicu, 312510

Succor cone: is it cervical conization a protective maneuver

ESGO eAcademy, Enrique Maria Chacon Cruz, 312509

Industry symposium - sponsored by Clinical Care Options: A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 313585

Industry symposium: A Walk in the PARP: Remodeling the Landscape of Newly Diagnosed Advanced Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 313081

Ovarian relapse; platinum not an option. State of the art lecture

ESGO eAcademy, Ignace Vergote, 312508

Ovarian relapse; platinum not an option. Set up the case

ESGO eAcademy, Jalid Sehouli, 312507

Ovarian first-line & Ovarian relapse; platinum an option

ESGO eAcademy, Faculty / Presenters, 313068

Ovarian relapse; platinum an option. State of the art lecture

ESGO eAcademy, Jonathan Ledermann, 312506

Ovarian relapse; platinum an option. Set up the case

ESGO eAcademy, Isabelle Ray-Coquard, 312505

Integrating PARPi in front line of advanced ovarian cancer

ESGO eAcademy, Antonio Gonzalez Martin, 313693

State of the art lecture 1st line Ovarian Cancer Treatment

ESGO eAcademy, Eric Lauraine, 312504

Ovarian first-line. Set up the case

ESGO eAcademy, Philipp Harter, 312503

Ovarian cancer surgery. Panel Discussion

ESGO eAcademy, Faculty / Presenters, 313657

Ovarian cancer surgery. State of the art lecture

ESGO eAcademy, Andreas du Bois, 312502

Ovarian cancer surgery. Set up the case

ESGO eAcademy, Luis Chiva, 312501

ESGO-ESMO ovarian cancer guidelines

ESGO eAcademy, Nicoletta Colombo, 312500